PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1389158
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1389158
A Vascular Access Device (VAD) is a medical device designed to provide access to a patient's bloodstream for various medical treatments, procedures, and interventions. It allows healthcare professionals to administer medications, fluids, nutrients, and blood products, as well as to monitor vital signs and draw blood samples without the need for repeated needle sticks. VADs are particularly useful in situations where long-term or frequent access to the bloodstream is required, such as for patients undergoing chemotherapy, dialysis, or intravenous (IV) therapy. They help to minimize the discomfort and potential complications associated with repeated needle insertions. The key factors driving the market growth is rising prevalence of lifestyle-related disorders, growing number of chemotherapy procedures with high hospitalization rates, and growing aging population that anticipated to support the market growth during forecast period.
Moreover, the growing aging population contributes to the increasing VAD market. The aging individuals are more likely to have multiple medical conditions concurrently, leading to a greater need for medical interventions. These patients might require multiple VADs for different purposes, such as central venous catheters for chemotherapy and peripherally inserted central catheters (PICCs) for antibiotics or nutrition. According to the World Bank, 8% of the total population aged 65 and older lived in the world in 2015, and in 2021 the rate reached 10 %. Additionally, the growing healthcare infrastructure development is anticipated to create the lucrative opportunity for the market growth during forecast period. However, the risks associated with catheter usage and stringent regulations and product recalls stifles market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Vascular Access Device Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the rising incidence of chronic diseases, increased demand for homecare settings, and growing prevalence of cancer. Whereas, the Asia Pacific is expected to grow with the fastest growth rate during the forecast period, owing to factors such as the increasing healthcare expenditure, growing aging population, rising chronic diseases, and supportive government initiatives that anticipated to support the market growth.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of tables and figures and dummy in nature, final lists may vary in the final deliverable